CompanyGraph
At a glance
- Depends onUpstream position: supplies 6 industries, depends on 0
- ScaleMarket cap is $240.09B, higher than 95% of all stocks globally
- FinancialsHigh earnings quality
- Interpretations1 currently firing — 1
Sign in to view price data.
Sign inWhat the company actually pays, and whether its own cash supports it.
Dividends view
Yield
4.34%Above 5Y avg (2.16%)
Annual Rate
CNY 56.05Paid semi-annual
Payout Ratio
79.9%Moderate
Payback Period
24.5 yr
Last Ex-Dividend
Jun 26, 2026
The reported statements, read against the company's own industry.
Financials view
Market Capitalization
1.61TCNY240.09B · vs all stocks (USD)
Trailing P/E
19.96xRevenue (TTM)
170.15BCNY25.30B · vs all stocks (USD)
Profit Margin
47.86%Beta
0.2860xvs all stocks
52-Week Change
-11.78%vs all stocks
Forward Annual Dividend Yield
4.34%vs all stocks
Market Capitalization
1.61TCNY240.09B · vs all stocks (USD)
Enterprise Value
1.58TCNY234.72B · vs all stocks (USD)
Trailing P/E
19.96xForward P/E
18.04xPEG Ratio
11.23xPrice to Sales (TTM)
9.38xPrice to Book (MRQ)
6.46xEnterprise to Revenue
9.28xEnterprise to EBITDA
14.10xGross Margin
89.91%Profit Margin
47.86%Operating Margin
62.34%Return on Assets (TTM)
22.83%Return on Equity (TTM)
33.00%Revenue (TTM)
170.15BCNY25.30B · vs all stocks (USD)
Revenue per Share (TTM)
135.90CNYUpdated Aug 20, 2026Quarterly Revenue Growth
-5.10%Gross Profit (TTM)
153.58BCNY22.84B · vs all stocks (USD)
EBITDA (TTM)
116.93BCNY17.39B · vs all stocks (USD)
Net Income (TTM)
81.43BCNY12.11B · vs all stocks (USD)
Quarterly Earnings Growth (YoY)
-6.90%Operating Cash Flow (TTM)
119.09BCNY17.71B · vs all stocks (USD)
Levered Free Cash Flow (TTM)
60.01BCNY8.92B · vs all stocks (USD)
Forward Annual Dividend Rate
56.05CNYUpdated Aug 20, 2026Forward Annual Dividend Yield
4.34%vs all stocks
Trailing Annual Dividend Rate
51.98CNYUpdated Aug 20, 2026Trailing Annual Dividend Yield
4.02%vs all stocks
5-Year Average Dividend Yield
2.16%vs all stocks
Payout Ratio
79.91%Minority Interest (Equity)
9.32BCNYFY2025 · Dec 31, 2025Revenue
172.05BCNYFY2025 · Dec 31, 2025Cost of Goods Sold
14.89BCNYFY2025 · Dec 31, 2025Gross Profit
157.16BCNYFY2025 · Dec 31, 2025Operating Income
114.07BCNY16.96B · vs all stocks (USD)
Pre-tax Income
114.76BCNYFY2025 · Dec 31, 2025Income Tax Expense
29.44BCNYFY2025 · Dec 31, 2025Net Income
85.31BCNYFY2025 · Dec 31, 2025EBIT
114.78BCNYFY2025 · Dec 31, 2025EBITDA (Income Statement)
116.93BCNYFY2025 · Dec 31, 2025Research & Development
190.11MCNYFY2025 · Dec 31, 2025Selling, General & Administrative
11.79BCNYFY2025 · Dec 31, 2025Other Operating Expenses
27.35BCNYFY2025 · Dec 31, 2025Non-operating Interest Income
842.99MCNYFY2025 · Dec 31, 2025Non-operating Interest Expense
28.73MCNYFY2025 · Dec 31, 2025EPS (Basic)
65.66CNYFY2025 · Dec 31, 2025EPS (Diluted)
65.66CNYFY2025 · Dec 31, 2025Basic Shares Outstanding
1.25BSharesFY2025 · Dec 31, 2025Diluted Shares Outstanding
1.25BSharesFY2025 · Dec 31, 2025Net Income from Continuing Operations
85.31BCNYFY2025 · Dec 31, 2025Minority Interests (P&L)
-2.99BCNYFY2025 · Dec 31, 2025Preferred Stock Dividends
0.00CNYFY2025 · Dec 31, 2025Operating Cash Flow
66.18BCNYFY2025 · Dec 31, 2025Free Cash Flow
63.05BCNYFY2025 · Dec 31, 2025Cash & Cash Equivalents (End of Period)
126.43BCNYFY2025 · Dec 31, 2025Starting Profit (CF Statement)
85.31BCNYFY2025 · Dec 31, 2025Other Non-cash Items
49.37MCNYFY2025 · Dec 31, 2025Change in Accounts Receivable (CF)
-10.98BCNYFY2025 · Dec 31, 2025Change in Other Assets/Liabilities
-8.19BCNYFY2025 · Dec 31, 2025Capital Expenditures
-3.13BCNYFY2025 · Dec 31, 2025Purchase of Investments
-62.10BCNYFY2025 · Dec 31, 2025Sale of Investments
33.57BCNYFY2025 · Dec 31, 2025Other Investing Activity
15.72MCNYFY2025 · Dec 31, 2025Net Investing Cash Flow
-31.64BCNYFY2025 · Dec 31, 2025Common Dividends Paid
-64.67BCNYFY2025 · Dec 31, 2025Other Financing Charges
-6.19BCNYFY2025 · Dec 31, 2025Net Financing Cash Flow
-70.86BCNYFY2025 · Dec 31, 2025Shares Outstanding
1.25BSharesUpdated Aug 20, 2026Float Shares
540.95MSharesUpdated Aug 20, 2026% Held by Insiders
62.12%vs all stocks
% Held by Institutions
7.22%vs all stocks
Total Cash (MRQ)
55.33BCNY8.23B · vs all stocks (USD)
Total Cash per Share (MRQ)
44.27CNYUpdated Aug 20, 2026Total Debt (MRQ)
243.68MCNY36.24M · vs all stocks (USD)
Total Debt to Equity (MRQ)
0.0009xCurrent Ratio (MRQ)
5.59xBook Value per Share (MRQ)
200.99CNYUpdated Aug 20, 2026Total Assets
303.83BCNY45.18B · vs all stocks (USD)
Total Current Assets
252.52BCNYFY2025 · Dec 31, 2025Total Liabilities
49.88BCNYFY2025 · Dec 31, 2025Total Non-current Assets
51.32BCNYFY2025 · Dec 31, 2025Total Non-current Liabilities
265.11MCNYFY2025 · Dec 31, 2025Total Current Liabilities
49.61BCNYFY2025 · Dec 31, 2025Cash
51.68BCNYFY2025 · Dec 31, 2025Cash Equivalents
14.45MCNYFY2025 · Dec 31, 2025Cash & Cash Equivalents
51.69BCNYFY2025 · Dec 31, 2025Accounts Receivable
2.61MCNYFY2025 · Dec 31, 2025Inventory
61.43BCNYFY2025 · Dec 31, 2025Accounts Payable
4.01BCNYFY2025 · Dec 31, 2025Short-term Debt
44.21MCNYFY2025 · Dec 31, 2025Other Current Liabilities
994.96MCNYFY2025 · Dec 31, 2025Long-term Debt
189.50MCNYFY2025 · Dec 31, 2025Common Stock (Book)
1.25BCNYFY2025 · Dec 31, 2025Retained Earnings
191.91BCNYFY2025 · Dec 31, 2025Total Shareholders' Equity
253.96BCNY37.77B · vs all stocks (USD)
Treasury Stock
120.11MCNYFY2025 · Dec 31, 202552-Week Low
1.15KCNYUpdated Aug 20, 202652-Week High
1.57KCNYUpdated Aug 20, 202652-Week Change
-11.78%vs all stocks
Beta
0.2860xvs all stocks
50-Day MA
1.27KCNYUpdated Aug 20, 2026200-Day MA
1.38KCNYUpdated Aug 20, 2026Avg 10-Day Volume
3.97MSharesUpdated Aug 20, 2026Avg 30-Day Volume
4.80MSharesUpdated Aug 20, 2026Diluted EPS (TTM)
65.03CNYUpdated Aug 20, 20261 interpretation currently present — each is a set of fired observations whose alignment reads as one structural pattern. Click an observation to see the numbers behind it.
Screen for these patternsIs this company financially stable?
MRQ Cash Elevated Relative To Total Debt With EBITDA And FCF Elevated Relative To Total Liabilities
Cash covers most of its debt, with earnings high against its liabilities.
Reads
An interpretation is present only while every observation it reads stays fired (score ≥ 70). It describes what the aligned readings show — never a verdict, never a prediction.
Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Financial Health
High earnings qualityNotable
Earnings Quality Score: 0.58
High structural barrier to entryNotable
Barrier to Entry: 1.10
Supply Chain
Upstream position: supplies 6 industries, depends on 0Notable
Outgoing: 6.00Incoming: 0.00
Scale
Market cap is $240.09B, higher than 95% of all stocks globallySignificant
Market cap (USD): 240,089,378,453.529Global P95: 25,614,208,870.135
Revenue is $25.3B, higher than 95% of all stocks globallySignificant
Revenue (USD): 25,303,304,148.419Global P95: 14,667,937,174.886
Levered free cash flow is $8.92B, higher than 95% of all stocks globallySignificant
Levered free cash flow (USD): 8,924,804,086.825Global P95: 1,123,592,359.78
Companies that share the same coordination system — how they create, deliver, or capture value.
L'Oréal S.A.
Tier 1ProductionBrand-Compounding ConsumerAttentionFlow
Nestlé S.A.
Tier 1ProductionBrand-Compounding ConsumerFlowAttention
LVMH Moët Hennessy Louis Vuitton SE
Tier 1ProductionBrand-Compounding ConsumerAttentionFlow
Hermès International Société en commandite par actions
Tier 1ProductionBrand-Compounding ConsumerAttentionFlow
Philip Morris International Inc.
Tier 1ProductionBrand-Compounding ConsumerFlowAttention
PepsiCo, Inc.
Tier 1ProductionBrand-Compounding ConsumerFlowAttention
Procter & Gamble Co
Tier 1ProductionBrand-Compounding ConsumerAttentionFlow
The Coca-Cola Company
Tier 1ProductionBrand-Compounding ConsumerFlowAttention
Anheuser-Busch InBev SA/NV
Tier 1ProductionBrand-Compounding ConsumerFlowAttention
Compagnie Financière Richemont SA
Tier 1ProductionBrand-Compounding ConsumerAttentionFlow
Companies that share active interpretations — structural patterns currently present in both stocks.
Hubei Jumpcan Pharmaceutical Co., Ltd.
1 interpretationMRQ Cash Elevated Relative To Total Debt With EBITDA And FCF Elevated Relative To Total Liabilities
CIE Automotive India Ltd.
1 interpretationMRQ Cash Elevated Relative To Total Debt With EBITDA And FCF Elevated Relative To Total Liabilities
Manhattan Associates Inc.
1 interpretationMRQ Cash Elevated Relative To Total Debt With EBITDA And FCF Elevated Relative To Total Liabilities